Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Innate Pharma

Start price
Target price
Perf. (%)
€3.51
01.02.22
€4.15
01.02.23
-7.69%
10.02.22

Could be worthwhile Investment >10% per year
buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.17
24.01.22
-
24.01.23
116.40%
25.01.23

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.90
23.01.22
-
23.01.23
-5.47%
06.02.22

Could be very worthwhile Investment >20% year
buy
Valneva SE

Start price
Target price
Perf. (%)
€17.56
13.01.22
€25.00
13.01.23
-67.08%
23.09.22

buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.12
10.01.22
-
10.01.23
-14.85%
01.02.22

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€17.12
10.01.22
-
10.01.23
-62.28%
11.01.23

buy
Valneva SE

Start price
Target price
Perf. (%)
€17.72
09.01.22
-
09.01.23
-10.27%
22.01.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€17.63
06.01.22
€10.00
06.01.23
-62.48%
06.01.23

buy
Valneva SE

Start price
Target price
Perf. (%)
€18.25
05.01.22
-
05.01.23
-6.36%
10.01.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€19.03
04.01.22
-
04.01.23
-7.46%
07.01.22

Risky Investment
Edap Tms S.A. ADR

Start price
Target price
Perf. (%)
€5.00
03.01.22
-
03.01.23
27.00%
15.05.22

Probably not worthwhile Investment
buy
Quantum Genomics S.A.

Start price
Target price
Perf. (%)
€4.32
31.12.21
€5.00
31.12.22
-97.78%
01.01.23

Could be worthwhile Investment >10% per year
buy
Eurobio scientific

Start price
Target price
Perf. (%)
€28.54
26.12.21
-
26.12.22
-32.45%
14.03.22

Could be worthwhile Investment >10% per year
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€10.64
24.12.21
-
24.12.22
-57.99%
25.12.22

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€24.34
21.12.21
-
21.12.25
-81.33%
12.01.24

buy
Valneva SE

Start price
Target price
Perf. (%)
€26.84
18.12.21
€30.00
18.12.22
-76.52%
19.12.22

buy
Ipsen S.A.

Start price
Target price
Perf. (%)
€88.00
17.12.21
-
17.12.22
10.51%
18.12.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€24.64
16.12.21
€33.00
31.12.23
-67.02%
07.09.22

Could be very worthwhile Investment >20% year
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€85.57
14.12.21
€124.00
14.12.22
5.18%
15.12.22

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
12.12.21
-
12.12.22
8.73%
25.12.21

Could be very worthwhile Investment >20% year
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
11.12.21
€30.00
11.12.22
8.73%
25.12.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
buy
Oncodesign S.A.

Start price
Target price
Perf. (%)
€8.61
08.12.21
€10.00
08.12.22
65.85%
09.12.22

Could be worthwhile Investment >10% per year
buy
Hybrigenics S.A.

Start price
Target price
Perf. (%)
€0.12
03.12.21
€0.25
03.12.22
-46.60%
04.12.22

Could be worthwhile Investment >10% per year
buy
Theradiag S.A.

Start price
Target price
Perf. (%)
€2.16
02.12.21
€2.80
02.12.22
4.86%
03.12.22

Could be worthwhile Investment >10% per year
buy
Abivax S.A.

Start price
Target price
Perf. (%)
€25.50
01.12.21
€28.00
01.12.22
-31.92%
20.05.22

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected